Stock listing
NASDAQ:IDIX Idenix Pharmaceuticals Inc Stock
Follow Idenix Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:IDIX
$24.50 USD
Close on Aug 5, 2014 · No longer trades
- Lowest – highest close
- $1.83 – $27.22 USDSince Jul 22, 2004 · lowest Nov 19, 2009 · highest Aug 2, 2005
Delisted NASDAQ:IDIX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IDIX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Idenix Pharmaceuticals Inc on 6ix
- Decks
- 2 decks · latest Sep 20, 2012
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2012) | Investor deck | 14 slides | Sep 20, 2012 |
| Corporate Update (January 2012) | Corporate update | 13 slides | Jan 9, 2012 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Wyzga Other companies: Tvardi Therapeutics, Inc. (Board Member · Since at least Apr 15, 2025); Mereo BioPharma Group plc (Chairman of the Board · Since at least Jan 1, 2024); X4 Pharmaceuticals, Inc. (Director · Since at least Mar 13, 2019); Kineta Inc. (See Remarks · Aug 16, 2021 – Dec 2, 2022 · Past); Invivyd, Inc. (Director · Aug 5, 2021 – May 23, 2023 · Past); LogicBio Therapeutics Inc (Director · Oct 18, 2018 – Nov 16, 2022 · Past); EXACT Sciences Corporation (Director · Feb 9, 2015 – Feb 26, 2021 · Past); Akebia Therapeutics, Inc. (Director · Mar 19, 2014 – Jun 14, 2018 · Past); OncoMed Pharmaceuticals Inc (Director · Oct 14, 2013 – Jun 22, 2018 · Past); Radius Health, Inc. (Chief Executive Officer, Director · Dec 5, 2011 – Dec 15, 2011 · Past); Genzyme Corp (Executive VP and CFO · May 25, 2006 – Apr 4, 2011 · Past) | Director · Mar 1, 2012 – Aug 5, 2014 · Past |
| Ronald C Renaud Jr Other companies: Kailera Therapeutics, Inc. (CEO & President, Director · Since at least Apr 16, 2026); Upstream Bio, Inc. (Director · Since at least Oct 10, 2024); Cerevel Therapeutics Holdings Inc (President & CEO, Director · Jun 12, 2023 – Aug 1, 2024 · Past); ImageneBio, Inc. (Director · Mar 25, 2021 – Jun 9, 2022 · Past); Atara Biotherapeutics, Inc. (Director · Apr 29, 2020 – Jun 23, 2022 · Past); Translate Bio Inc (Chief Executive Officer, Director · Jun 27, 2018 – Sep 14, 2021 · Past); Chimerix Inc (Director · Dec 17, 2014 – Jun 20, 2019 · Past); Akebia Therapeutics, Inc. (Director · Sep 12, 2014 – Jun 14, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2014 – Jan 3, 2017 · Past); Keryx Biopharmaceuticals Inc (Chief Financial Officer · Feb 14, 2006 – Feb 14, 2007 · Past) | President & CEO, Director · Jun 28, 2007 – Aug 5, 2014 · Past |
| Charles A Rowland Jr Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 3, 2022 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 2, 2021 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); BIND Therapeutics Inc (Director · May 28, 2014 – Jun 21, 2016 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past) | Director · Jun 6, 2013 – Aug 5, 2014 · Past |
| Pamela Thomas-Graham Other companies: Compass, Inc. (Board Member · Since at least Mar 31, 2021); Bumble Inc. (Director · Since at least Feb 10, 2021); Peloton Interactive, Inc. (Director · Since at least Sep 25, 2019); Anthemis Digital Acquisitions I Corp (Director · Oct 27, 2021 – Oct 27, 2021 · Past); Rivian Automotive, Inc. (Director · Aug 12, 2021 – Jun 18, 2024 · Past); Norwegian Cruise Line Holdings Ltd. (Director · Apr 23, 2018 – Jan 4, 2021 · Past); Clorox Company (the) (Director · Jan 17, 2006 – Dec 31, 2020 · Past) | Director · Jun 14, 2006 – Jun 2, 2009 · Past |
| David Arkowitz Other companies: iBio, Inc. (Director · Since at least Nov 21, 2024); Kineta Inc. (Director · Since at least Mar 6, 2019); Seres Therapeutics, Inc. (Chief Financial Officer · Jun 1, 2021 – Feb 14, 2024 · Past); Flexion Therapeutics Inc (Chief Financial Officer · May 7, 2018 – May 10, 2021 · Past); Spring Bank Pharmaceuticals Inc (Director · May 5, 2016 – Jun 24, 2020 · Past); AMAG Pharmaceuticals Inc (EVP, CFO and CBO · Apr 5, 2007 – May 31, 2011 · Past) | Chief Financial Officer · Mar 7, 2006 – Mar 6, 2007 · Past |
| Brian Goff Other companies: Intellia Therapeutics, Inc. (Independent Director · Since at least Jun 13, 2024); Agios Pharmaceuticals, Inc. (Chief Executive Officer · Since at least Aug 8, 2022); Alexion Pharmaceuticals Inc (EVP & Chief Commercial Officer · Jun 1, 2017 – Jul 21, 2021 · Past); Baxalta Inc (EVP and President, Hematology · Jun 30, 2015 – Jun 3, 2016 · Past) | Director · Mar 27, 2012 – Mar 27, 2012 · Past |
| Denise Pollard-Knight Other companies: Mereo BioPharma Group plc (Chief Executive Officer, Director · Since at least Jan 1, 2024); Elanco Animal Health Incorporated (Director · Since at least Mar 11, 2019); Albireo Pharma Inc (Director · Nov 3, 2016 – Jun 16, 2017 · Past); OncoMed Pharmaceuticals Inc (Director · Jul 17, 2013 – Jun 22, 2018 · Past) | Director · Jun 14, 2006 – Aug 5, 2014 · Past |
| Jean-Pierre Sommadossi Other companies: Atea Pharmaceuticals, Inc. (Chairman & CEO, Atea Pharmaceuticals · Since at least Oct 29, 2020); ABG Acquisition I Corp (Director · Feb 16, 2021 – Mar 1, 2023 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 28, 2021 · Past) | President, CEO, Chairman, Director · Dec 31, 2005 – Feb 10, 2010 · Past |
| Wayne T Hockmeyer Other companies: Baxalta Inc (Director · Jun 9, 2015 – Jun 3, 2016 · Past); GenVec Inc (Director · Jun 16, 2010 – Jun 16, 2017 · Past); Baxter International Inc. (Director · May 4, 2010 – May 5, 2015 · Past) | Director · Jun 3, 2010 – Aug 5, 2014 · Past |
| Charles W Cramb Jr Other companies: Avon Products Inc (Vice Chairman · Mar 31, 2006 – Jun 15, 2011 · Past); Tenneco Inc (Director · Jan 1, 2006 – Jan 18, 2012 · Past) | Director · Jun 14, 2006 – Jun 2, 2011 · Past |
All 18 people
| Person | Seat |
|---|---|
| Douglas L Mayers Other companies: Cocrystal Pharma, Inc. (CHIEF MEDICAL OFFICER · Oct 1, 2015 – Oct 1, 2015 · Past) | EVP and Chief Medical Officer · Mar 29, 2007 – Aug 5, 2014 · Past |
| Jacques Dumas Other companies: Tetraphase Pharmaceuticals Inc (Chief ScientificOfficer · Jun 8, 2016 – Jan 17, 2019 · Past) | EVP, Chief Scientific Officer · Feb 11, 2014 – Aug 5, 2014 · Past |
| John Weidenbruch Other companies: APP Pharmaceuticals Inc (Acting General Counsel · Jan 19, 2006 – Jan 19, 2006 · Past) | Ex. VP, Gen. Counsel and Secr. · Sep 1, 2006 – Feb 10, 2010 · Past |
| Susan Koppy Other companies: Paratek Pharmaceuticals Inc (VP, Corporate Development · Jan 30, 2009 – Feb 12, 2009 · Past) | Sr. VP, Business and Corp Dev. · Jan 18, 2006 – Jul 13, 2007 · Past |
| David Standring | EVP & Chief Scientific Officer · Feb 22, 2008 – Feb 20, 2013 · Past |
| Emmanuel Puginier | Director · Nov 23, 2007 – Nov 23, 2007 · Past |
| Nathaniel Brown | Chief Medical Officer · Mar 7, 2006 – Mar 7, 2006 · Past |
| Paul Fanning | SVP, Human Resources · Feb 22, 2008 – Aug 5, 2014 · Past |
Log in to ask 6ix AI your own questions about Idenix Pharmaceuticals Inc.